
Sign up to save your podcasts
Or


Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
By Michael Putman4.9
113113 ratings
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965

322 Listeners

502 Listeners

883 Listeners

127 Listeners

1,157 Listeners

119 Listeners

193 Listeners

172 Listeners

69 Listeners

254 Listeners

4 Listeners

182 Listeners

11 Listeners

20 Listeners

5 Listeners